Portfolio News

Accolade Unveils Maya Intelligence Engine & App to Deliver Personalized Healthcare Experience

Healthcare concierge company Accolade recently unveiled its new Maya Intelligence Engine, which will provide highly personalized healthcare support for individuals and their families. It also introduced the Accolade Mobile app, which enables live messaging with dedicated health assistants and nurses on any health- or benefits-related question or concern. Maya’s intelligence becomes more relevant, efficient, and effective with every interaction between patients and Accolade Health assistants and nurses. The Accolade platform and Maya have produced a 70% engagement level across employer populations, member satisfaction ratings of 98%,...

Dementia Products Are Now Available to Buy on the High Street For the Very First Time

Unforgettable, the UK’s leading authority on dementia services, has teamed up with Lloyds Pharmacy to provide a range of dementia aide products to Lloyds customers. The collection includes seven products designed to make the lives of dementia patients and their caretakers easier, such as a 2-in-1 day clock, an easy eating kit, 35-piece jigsaw puzzles, and a shining star cube designed to calm and soothe restlessness. The partnership launched after research revealed that half of Britain’s population are more fearful about having to care for someone with...

Shop Targets Dementia Sufferers With Talking Clocks and Jigsaws

Lloyds Pharmacy has begun stocking products for people with dementia. The store chain will sell seven items made by Unforgettable in 59 of its stores, with more Unforgettable products available on the Lloyds Pharmacy website. The items to be sold include a talking alarm clock that can record messages for up to six daily alarms, a clock that can display text such as “Now it’s Saturday morning,” and a “fiddle muff” to keep a person’s hands occupied and reduce repetitive behavior. Lloyds will also sell a Family...

There’s an “Arms Race” in Early Cancer Detection Start-Ups, and SoftBank Just Plowed $360 Million into One of Them

The liquid biopsy space is increasingly full of up-and-coming new companies hoping to pave the way for an enhanced set of diagnostic tests and treatments for cancer. But this kind of technology, while more possible scientifically than ever before, requires a huge amount of funding. That’s why the news lately has been full of healthcare start-ups trumpeting their impressive achievements when it comes to getting investors on board. Most recently, Silicon Valley’s Guardant Health acquired $360 million from a round of fundraising led by technology conglomerate...

With $360M in New Financing, Guardant Health Prepares to Sequence One Million Cancer Patients

Guardant Health, based in Redwood, California, has secured $360 million in investor financing, making it the newest horse in the race to use liquid biopsy technology to significantly advance cancer testing and treatment. Guardant will use this round of financing to expand its work both nationally and internationally, particularly with regard to early cancer detection. Guardant’s Project LUNAR, launched in 2016, will no doubt be the backbone of the company’s ambitious new plan to sequence tumor DNA in one million cancer patients over the next five...